Analystreport

Aptevo Therapeutics Inc (NASDAQ: APVO) had its "buy" rating re-affirmed by analysts at Roth Capital.

Aptevo Therapeutics Inc.  (APVO) 
Last aptevo therapeutics inc. earnings: 8/9 09:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.aptevotherapeutics.com/investor-overview